Description
NDC: 82584-792-25
Akten (Lidocaine HCl 3.5%) Ophthalmic Gel, 1 mL — Théa Pharma Inc.
| Active ingredients | Lidocaine hydrochloride 3.5% (35 mg/mL) |
| Dosage form | Ophthalmic gel |
| Route | Topical ophthalmic |
| Size | 1 mL single-patient-use tube |
| Manufacturer | Théa Pharma Inc. |
| NDC | 82584-792-25 |
Indications and Usage
An amide local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures, in adult and pediatric patients.
Dosage and Administration
The recommended dose is 2 drops applied to the ocular surface in the area of the planned procedure. The gel may be reapplied as needed to maintain the anesthetic effect. It is administered by a healthcare provider.
Warnings and Precautions
- Not for injection or intraocular administration
- Prolonged use may cause permanent corneal damage
- Patients should not touch the eye for at least 10 to 20 minutes after application
- Not intended for patient self-administration
Contraindications
None.
Adverse Reactions
The most common adverse reactions include conjunctival hyperemia, corneal epithelial changes, headache, and a burning sensation upon application.
Storage and Handling
Store at 15°C to 25°C (59°F to 77°F) in the original carton, protected from light. Discard after use.
How Supplied
Supplied as a clear ophthalmic gel in single-patient-use 1 mL tubes, available individually or in cartons of 25 tubes.
Professional use only. Clinical information summarized from FDA-approved prescribing information (Structured Product Labeling); refer to the full prescribing information via DailyMed for complete details.
If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.
